Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MCET > SEC Filings for MCET > Form 8-K on 3-Oct-2013All Recent SEC Filings

Show all filings for MULTICELL TECHNOLOGIES, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for MULTICELL TECHNOLOGIES, INC.


3-Oct-2013

Entry into a Material Definitive Agreement, Other Events, Financial


Item 1.01 Entry Into A Material Definitive Agreement

On September 27, 2013, MultiCell Technologies, Inc. (the "Company") entered into a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the current research project with the University Health Network ("UHN") to evaluate MCT-485 in animal models for the treatment of primary liver cancer (the "Ghanekar Agreement"). As previously disclosed on the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on July 11, 2011 (the "2011 Form 8-K"), on July 5, 2011, the Company entered into a sponsored research agreement with UHN pursuant to which UHN evaluated the Company's product candidates, MCT-465 and MCT-485, in in vitro models for the treatment of primary liver cancer (the "UHN Agreement"). The mechanism of action of MCT-465 and MCT-485 and their potential selective effect on liver cancer stem cells were also evaluated. Under the terms of each of the Ghanekar Agreement and the UHN Agreement, the Company retains exclusive access to the research findings and intellectual property resulting from the research activities preformed by each of Dr. Ghanekar and UHN, respectively. The foregoing description of the UHN Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the UHN Agreement, a copy of which is attached to the 2011 Form 8-K as Exhibit 10.1.



Item 8.01 Other Events

On October 2, 2013, the Company issued a press release announcing that the Company had entered into the Ghanekar Agreement.

This summary is qualified in its entirety by reference to the Press Release, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. The Press Release and the information therein are being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.



Item 9.01 Financial Statements and Exhibits

(d)

Exhibit No. Description
99.1 Press Release dated October 2, 2013.

  Add MCET to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MCET - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.